Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary?
Abstract Background Bordetella pertussis infection is a known trigger of atypical hemolytic uremic syndrome (HUS). For patients suspected of having atypical HUS, prompt plasma exchange/infusion (PE/PI) or eculizumab (ECZ) treatment is recommended. Case presentation We report a 1-month-old female inf...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-1168-y |
id |
doaj-e17056703b114332a6e3665e731e3504 |
---|---|
record_format |
Article |
spelling |
doaj-e17056703b114332a6e3665e731e35042020-11-25T02:55:11ZengBMCBMC Nephrology1471-23692018-12-011911410.1186/s12882-018-1168-yTreatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary?Ken Saida0Masao Ogura1Yuji Kano2Shingo Ishimori3Takahisa Yoshikawa4Hiroko Nagata5Mai Sato6Koichi Kamei7Kenji Ishikura8Division of Nephrology and Rheumatology, National Center for Child Health and DevelopmentDivision of Nephrology and Rheumatology, National Center for Child Health and DevelopmentDivision of Nephrology and Rheumatology, National Center for Child Health and DevelopmentDepartment of Pediatrics, Kakogawa Central City HospitalDivision of Nephrology and Rheumatology, National Center for Child Health and DevelopmentDivision of Nephrology and Rheumatology, National Center for Child Health and DevelopmentDivision of Nephrology and Rheumatology, National Center for Child Health and DevelopmentDivision of Nephrology and Rheumatology, National Center for Child Health and DevelopmentDivision of Nephrology and Rheumatology, National Center for Child Health and DevelopmentAbstract Background Bordetella pertussis infection is a known trigger of atypical hemolytic uremic syndrome (HUS). For patients suspected of having atypical HUS, prompt plasma exchange/infusion (PE/PI) or eculizumab (ECZ) treatment is recommended. Case presentation We report a 1-month-old female infant who was admitted with a severe cough and a B. pertussis-positive sputum culture. She was born at 38 weeks gestation and did not have a family history of renal diseases. Hemophagocytic syndrome was suspected and she was transferred to our hospital 17 days after her initial admission. One day later, she developed acute kidney injury and was diagnosed with HUS triggered by B. pertussis infection. Her plasma complement levels were low and her kidney function continued to worsen over the next few days. However, prior to starting ECZ treatment, her kidney function improved spontaneously; she did not receive PE/PI or ECZ. She was discharged 46 days after her initial hospitalization, without complications. A genetic workup revealed no mutations in CFH, CFI, CFB, C3, MCP, THBD, or DGKE. Conclusions This case demonstrates that B. pertussis infection-related HUS may resolve spontaneously. The decision to treat during the acute phase is challenging because B. pertussis often affects infants suspected of having atypical HUS. However, ECZ may not be the first treatment option for patients with B. pertussis infection-related HUS unless they show an indicated genetic abnormality; if ECZ is used, early discontinuation should be considered.http://link.springer.com/article/10.1186/s12882-018-1168-yAtypical hemolytic uremic syndromeBordetella pertussisEculizumabPlasma exchange |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ken Saida Masao Ogura Yuji Kano Shingo Ishimori Takahisa Yoshikawa Hiroko Nagata Mai Sato Koichi Kamei Kenji Ishikura |
spellingShingle |
Ken Saida Masao Ogura Yuji Kano Shingo Ishimori Takahisa Yoshikawa Hiroko Nagata Mai Sato Koichi Kamei Kenji Ishikura Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary? BMC Nephrology Atypical hemolytic uremic syndrome Bordetella pertussis Eculizumab Plasma exchange |
author_facet |
Ken Saida Masao Ogura Yuji Kano Shingo Ishimori Takahisa Yoshikawa Hiroko Nagata Mai Sato Koichi Kamei Kenji Ishikura |
author_sort |
Ken Saida |
title |
Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary? |
title_short |
Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary? |
title_full |
Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary? |
title_fullStr |
Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary? |
title_full_unstemmed |
Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection —is plasma exchange or eculizumab use necessary? |
title_sort |
treatment of hemolytic uremic syndrome related to bordetella pertussis infection —is plasma exchange or eculizumab use necessary? |
publisher |
BMC |
series |
BMC Nephrology |
issn |
1471-2369 |
publishDate |
2018-12-01 |
description |
Abstract Background Bordetella pertussis infection is a known trigger of atypical hemolytic uremic syndrome (HUS). For patients suspected of having atypical HUS, prompt plasma exchange/infusion (PE/PI) or eculizumab (ECZ) treatment is recommended. Case presentation We report a 1-month-old female infant who was admitted with a severe cough and a B. pertussis-positive sputum culture. She was born at 38 weeks gestation and did not have a family history of renal diseases. Hemophagocytic syndrome was suspected and she was transferred to our hospital 17 days after her initial admission. One day later, she developed acute kidney injury and was diagnosed with HUS triggered by B. pertussis infection. Her plasma complement levels were low and her kidney function continued to worsen over the next few days. However, prior to starting ECZ treatment, her kidney function improved spontaneously; she did not receive PE/PI or ECZ. She was discharged 46 days after her initial hospitalization, without complications. A genetic workup revealed no mutations in CFH, CFI, CFB, C3, MCP, THBD, or DGKE. Conclusions This case demonstrates that B. pertussis infection-related HUS may resolve spontaneously. The decision to treat during the acute phase is challenging because B. pertussis often affects infants suspected of having atypical HUS. However, ECZ may not be the first treatment option for patients with B. pertussis infection-related HUS unless they show an indicated genetic abnormality; if ECZ is used, early discontinuation should be considered. |
topic |
Atypical hemolytic uremic syndrome Bordetella pertussis Eculizumab Plasma exchange |
url |
http://link.springer.com/article/10.1186/s12882-018-1168-y |
work_keys_str_mv |
AT kensaida treatmentofhemolyticuremicsyndromerelatedtobordetellapertussisinfectionisplasmaexchangeoreculizumabusenecessary AT masaoogura treatmentofhemolyticuremicsyndromerelatedtobordetellapertussisinfectionisplasmaexchangeoreculizumabusenecessary AT yujikano treatmentofhemolyticuremicsyndromerelatedtobordetellapertussisinfectionisplasmaexchangeoreculizumabusenecessary AT shingoishimori treatmentofhemolyticuremicsyndromerelatedtobordetellapertussisinfectionisplasmaexchangeoreculizumabusenecessary AT takahisayoshikawa treatmentofhemolyticuremicsyndromerelatedtobordetellapertussisinfectionisplasmaexchangeoreculizumabusenecessary AT hirokonagata treatmentofhemolyticuremicsyndromerelatedtobordetellapertussisinfectionisplasmaexchangeoreculizumabusenecessary AT maisato treatmentofhemolyticuremicsyndromerelatedtobordetellapertussisinfectionisplasmaexchangeoreculizumabusenecessary AT koichikamei treatmentofhemolyticuremicsyndromerelatedtobordetellapertussisinfectionisplasmaexchangeoreculizumabusenecessary AT kenjiishikura treatmentofhemolyticuremicsyndromerelatedtobordetellapertussisinfectionisplasmaexchangeoreculizumabusenecessary |
_version_ |
1724717778697453568 |